<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03886857</url>
  </required_header>
  <id_info>
    <org_study_id>SCS-CorE_AT</org_study_id>
    <nct_id>NCT03886857</nct_id>
  </id_info>
  <brief_title>Segmental Mechanisms of Transcutaneous Spinal Cord Stimulation for Spasticity Control</brief_title>
  <acronym>SCS_CorE_AT</acronym>
  <official_title>Carry-over Effects of Transcutaneous Spinal Cord Stimulation for Spasticity Control on Inhibitory Circuits of the Spinal Cord: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Lackner</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Otto Wagner Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the pilot study is to gain first insights into the interaction of transcutaneous
      spinal cord stimulation with the altered activity of intraspinal circuits associated with
      spinal spasticity. The main goal is to evaluate the validity of the chosen measures and to
      generate a data base for statistical planning of a subsequent clinical study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>H_max/M_max</measure>
    <time_frame>2 hours post-intervention</time_frame>
    <description>Ratio of the maximum H reflex and the maximum M wave</description>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcutaneous spinal cord stimulation</intervention_name>
    <description>noninvasive electrical stimulation of the human lumbar spinal cord</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        written informed consent prior to participation

        for participants with intact CNS:

        • no previous neurological or musculoskeletal disorders

        for participants with spinal cord injury:

          -  Spinal cord injury due to trauma

          -  ≥ 12 months post-spinal cord injury

          -  complete or incomplete spinal cord injury classified as grade C or D on the American
             Spinal Injury Association Impairment Scale (AIS)

          -  neurological level of spinal cord injury: C3-T10

          -  preserved tendon and cutaneo-muscular reflexes in the lower limbs

        Exclusion Criteria:

          -  other neuromuscular diseases, e.g., amyotrophic lateral sclerosis (ALS), Parkinson's
             disease, Guillain-Barré syndrome, muscular dystrophy

          -  active implants (e.g., cardiac pacemaker, drug pump)

          -  passive implants at vertebral level T10 or caudal (e.g., metal screws/plates for
             surgical stabilization of spinal fractures)

          -  active infections or diseases, pressure sores

          -  dermatological issues at the stimulation site

          -  malignant diseases

          -  heart insufficiency (NYHA III-IV)

          -  potential pregnancy (pregnancy test to be conducted in women of child bearing age
             before application of transcutaneous spinal cord stimulation)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ursula Hofstoetter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ursula Hofstoetter, PhD</last_name>
    <phone>+43 1 40400</phone>
    <phone_ext>19720</phone_ext>
    <email>ursula.hofstoetter@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Otto Wagner Hospital</name>
      <address>
        <city>Vienna</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Lackner, Prof., MD</last_name>
      <phone>+43 91060</phone>
      <phone_ext>20708</phone_ext>
      <email>peter.lackner@wienkav.at</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 18, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>July 2, 2019</last_update_submitted>
  <last_update_submitted_qc>July 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Otto Wagner Hospital</investigator_affiliation>
    <investigator_full_name>Peter Lackner</investigator_full_name>
    <investigator_title>Chief Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

